Medical Analysis Update: VICP Advisory Commission on Childhood Vaccines June 10-11, 2010 Rosemary Johann-Liang, MD

Slides:

Advertisements

Similar presentations

The Evolving Adult Immunization Platform

Advertisements

Vaccine Update and Refresher for Immunizations: 2012 Krista D. Capehart, PharmD, MSPharm, AE-C David G. Bowyer, R. Ph. Assistant Professors of Pharmacy.

Julianne Gee, MPH Immunization Safety Office

How many points did he average per game that NBA season?

IMMUNIZATION Immunization??? Reduce mortality and morbidity of mathernal and baby.

Fainting and Anaphylaxis Needlestick Injuries Bryna Warshawsky, MDCM, FRCPC Associate Medical Officer of Health Middlesex-London Health Unit.

Tom Shimabukuro, MD, MPH, MBA Immunization Safety Office Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious.

Flexibility. Adhesive Capsulitis What is it? Adhesive Capsulitis Painful restricted ROM Early loss of ER Normal x-rays Occurs in middle-age –aged females.

Adult Vaccination Update Walter W. Williams, M.D., M.P.H. Medical Epidemiologist, NCIRD National Adult and Influenza Immunization Summit Provider Work.

Diseases Caused by Bacteria

Should Vaccinations be required for students?. Some Pertinent Facts All 50 states require vaccinations for children entering public schools even though.

1 One Year Post-Exclusivity Adverse Event Review: Ertapenem Pediatric Advisory Committee Meeting November 16, 2006 Alan M. Shapiro, MD, PhD, FAAP Medical.

Vaccine Safety Concerns  Past of vaccines  Now most parents have never seen a case of diphtheria, measles, or other once- common diseases.  They therefore.

Vaccines and Related Biological Products Advisory Committee Presentation on Sanofi Pasteur’s H5N1 Vaccine Andrea N. James, M.D. Senior Medical Officer.

What's New on the Child and Adolescent Immunization Schedules William L. Atkinson, MD, MPH National Center for Immunization and Respiratory Diseases William.

Childhood Immunization Update for WIC and Clerical Personnel Presented by: Date:

1 One Year Post-Exclusivity Adverse Event Review for Tamiflu® (oseltamivir) Pediatric Advisory Committee Meeting November 18, 2005 Melissa M. Truffa, R.Ph.

TM 2011 Immunization Recommendations H. Cody Meissner, M.D. Professor of Pediatrics Tufts University School of Medicine Boston Floating Hospital for Children.

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.

TM Prepared for your next patient. Review of Selected Changes to the 2012 Immunization Schedules H. Cody Meissner, MD Floating Hospital for Children Tufts.

Lowering your handicap with Stata Tim Collier Medical Statistics Department, LSHTM & Leaside Golf Club, Edmonton.

Ken Falci, Ph.D.,Director, OSAS Center for Food Safety and Applied Nutrition (CFSAN) FDA, College Park, MD.

The National Vaccine Injury Compensation Program (VICP) Division of Vaccine Injury Compensation Update Advisory Commission on Childhood Vaccines December.

Collecting data in clinic.  Aim of BADBIR  Definition of Adverse Events  Adverse events in BADBIR  Adverse event recording in hospital case notes.

Carol Mansfield, M.D., M.P.H. Winthrop Pediatrics and Adolescent Medicine.

Economic Evaluation of Routine Childhood Immunization with DTaP, Hib, IPV, MMR and HepB Vaccines in the United States, 2001 Fangjun Zhou Health Services.

Immunization and the Patient. Low immunization rates Opportunity missed Health care delivery Inadequate access Lack of public awareness Religious beliefs.

5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees

Administrator Meeting September 16, 2015 Kim Elliott, Ph.D., C.P.H.Q. Administrator, Clinical Quality Management.

Vaccines For Children Coordinator Connecticut Immunization Program 1.

Figure 1 - Frequency Distribution of All VAERS LYMErix® Reports by Age at Onset of Adverse Event Age not available for 171 (16%) reports Interpretation.

Multiple Personality Disorder. Multiple personality disorder is more formally known as dissociative identity disorder.

Global Training Network ProgrammeWorld Health Organization A medical incident that takes place after an immunization, causes concern, and is believed to.

  TOTAL ENROLLED 21,776  TOTAL SURVEYED18,834 (86%)  TOTAL RECORDS18,209 (97%)  TOTAL MEDICAL EXEMPTIONS 224 (1.2%)  TOTAL PROVISIONALLY.

METHOD METHOD Long-Term Neuropsychological Functioning Following Mild Traumatic Brain Injury Nathalie C. Bérard and Dennis P. Alfano CONCLUSIONS The group.

BCG Vaccine Usual reactions induration: 2 – 4 wks pustule formation: 5 – 7 wks scar formation: 2 – 3 months Accelerated Reactions: induration: 2-3 days.

THE VACCINE CONTROVERSY Presented by: Joseph Goodfellow.

Review of Inpatient Musculoskeletal Consults Utilizing Musculoskeletal Ultrasound Mindy Loveless, MD Clinical Assistant Professor University of Washington.

OTC NSAID and ASA GI Bleeding Analysis of Spontaneous Reports Nonprescription Drugs Advisory Committee Meeting Joyce P. Weaver, Pharm.D. Office of Drug.

Torticollis Lauren Jones, Marina Castanedo & Randy Eang.

FDA Review of Clinical Safety Data Omalizumab for treatment of Allergic Asthma Genentech, Inc. FDA/Center for Biologics Evaluation and Research.

Update from the Office of Vaccines Research and Review, CBER/FDA NVAC Meeting Washington, D.C. February 4-5, 2003.

Review of Inpatient Musculoskeletal Consults Utilizing Musculoskeletal Ultrasound Mindy Loveless, MD Clinical Assistant Professor University of Washington.

Zelnorm ® (tegaserod) Division of Gastrointestinal and Coagulation Drug Products Division of Drug Risk Evaluation Gary Della’Zanna, D.O., M.Sc., F.A.C.O.S.

Review Update: QT Prolongation with Citalopram and Escitalopram Pediatric Advisory Committee Meeting November 16, 2006 Prepared by M. Lisa Jones, MD Division.

Facility ID:Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M*Date of Birth: Ethnicity (specify):Race.

mild Decompression for the Treatment of Lumbar Spinal Stenosis

1 Update to Post-Exclusivity Pediatric Adverse Event Review: Oxybutynin Pediatric Advisory Committee Meeting November 16, 2006 Lisa Mathis, MD, Associate.

C-1 Safety Results S. aureus Bacteremia and Endocarditis Study Gloria Vigliani, M.D. Vice President, Medical Strategy Cubist Pharmaceuticals.

Pediatric Advisory Committee: Overview of Role and Evolution of Process Dr. Dianne Murphy Director, Office of Pediatric Therapeutics, OC, FDA November.

When to give them how often and the diseases they prevent.

1 Syncope and Related Injuries after Vaccination Wan-Ting Huang, MD Immunization Safety Office Office of the Chief Science Officer The 42 nd National Immunization.

National Vaccine Injury Compensation Program Geoffrey Evans, MD Department of Health and Human Services Health Resources and Services Administration Director,

1 Review of the Vaccine Adverse Event Reporting System (VAERS) Beth Hibbs RN, MPH; Elaine Miller RN, MPH Immunization Safety Office (ISO) Division of Healthcare.

Beth Hibbs, RN, MPH Immunization Safety Office - Division Of Healthcare Quality Promotion, Centers for Disease Control and Prevention Vaccination Errors.

VACCINATIONS AND IMMUNISATIONS Science Group, Buxton U3A 20 th September 2013 Dr Marion Overton.

Job Corps Webinar: Immunizations John Kulig MD MPH Lead Medical Specialist September 29 & 30, 2010.

© 2010 ALL RIGHTS RESERVED PROPRIETARY AND CONFIDENTIAL INFORMATION OF CLEVELAND CLINIC June 2014 Collection of Patient-Reported Outcomes in Clinical Practice.

FY 2016 GPRA/GPRAMA update: CA Urban December 2015.

National Vaccine Injury Compensation Program HRSA The National Vaccine Injury Compensation Program (VICP): What’s New? National Immunization Conference.

TM Influenza Vaccine Safety in Children: Data from VAERS John Iskander MD MPH Gina Mootrey DO MPH Penina Haber MPH Roseanne English-Bullard BS.

Updating the Vaccine Injury Table (VIT) following the 2011 Institute of Medicine (IOM) Report on Adverse Effects of Vaccines Rosemary Johann-Liang, M.D.

Diseases Caused by Bacteria

Vaccination Rates in Idaho: Updates Fall 2017

10 Things You Should Know About HPV

Quadrivalent Human Papillomavirus Vaccine (HPV4) Adverse Events

10 Things You Should Know About HPV

Pediatric Inactivated Influenza Vaccine Safety VAERS Reports for Trivalent Inactivated Influenza Vaccine (TIV) in Infants/Toddlers Ann McMahon, MD, MS.

Changes in the proportion (95% CI) of patients with (A) fatal events, (B) serious infections, (C) malignancy, (D) GI perforation, and (E) serious cardiac.

Healthy People 2010 Focus Area 14

Presentation transcript:

Medical Analysis Update: VICP Advisory Commission on Childhood Vaccines June 10-11, 2010 Rosemary Johann-Liang, MD

Number of Petitions for Medical Analysis 5 year period: FY

Claims filed to VICP Comparing %age-bands 10 years apart

FY 2009 Claims Filed to VICP

2010 Medical (MO) Reviews: New Reports FY months so far N=498 reports total N=155 are activated autism reviews

3/10-5/10 MO Reviews: Age

3/10-5/10 MO Reviews: Vaccines Alleged (non-autism) Vaccine Alleged% of totalVaccine Alleged% of total Influenza45%Rotavirus4% HPV13%Meningococcal4% Tetanus8%Varicella2% Hepatitis B6% MMR5%Multiple12.5%

3/10-5/10 MO Reviews: Adverse Events (non-autism) AE% of totalAE% of total GBS30%Death6% Other Demyelinating TM/ADEM/CIDP/NMO/MS 12%Underlying Disorder5% Skin (rash, allergy, fascitis) 7%Immune/Rheum, autoimmune Injuries 5% Shoulder/Arm Injuries (BN, CRPS) 6%Miscellaneous (gastrointestinal, cardiac, hematologic, etc.) 24% Encephalitis, Sz Encepholopathy, 6%

HPV Claim: Demographics Total # of claims thus far since 2008 = 54 with 5 death claims Average age = 16.5 years for all female claims with range (12 – 27 yrs) Only one male claim (age over 50 years). 39% had HPV x 1; 32% had HPV x 2 and 29% had HPV x 3 16% of total had other concurrent vaccines (meningococcal, hepatitis A, hepatitis B, and Tetanus-containing)

HPV MO Reviews On-going: Injuries Claimed Claimed Injury% of totalClaimed Injury% of total Neurologic (other) Including seizures 24%Syncope “serious sequelae” 6% GBS17%Miscellaneous (GI, cardiac, hematologic) 12% TM/ADEM 7%Death Claims under review (hypercoagulable state, cardiac) some waiting for records those with autopsy – we will request slides for independent pathology review Rheumatologic 19% CTD 6%

Shoulder Injury Case Series Bodor M and Montalvo E. Vaccination-related shoulder dysfunction; Vaccine 25 (2007) –Case reports of 2 patients; pain within 2 days following vaccination; injection too high on shoulder? Medical Analysis of VICP Claims from ; 11 claims identified with significant shoulder pain and dysfunction following vaccine administration

Shoulder Series: Initial Analyses 82% female; Mean age = 52 (range 29-83) Vaccine Administered; 64% influenza; 36% tetanus- containing Pain onset is less than 24 hrs in 91% from vaccine administration with 64% recalling immediate symptom onset. Diagnoses: bursitis, rotator cuff injury, adhesive capsulitis Concern: long-term sequelae Concern: where and how administered